In the pharmaceutical industry, getting medications to market is a top priority; dealing with or- der fulfillment and managing returned product is equally challenging. At Lupin Pharmaceuticals, Inc., the U.S. subsidiary of one of India’s top five pharmaceutical companies, technology is woven into the fabric of the company’s research and development and manufacturing operations. But the returned product reconciliation process was bogged down

Join for free to read